Answers are grounded in this paper and cite their sources.
The structure-based design and subsequent chemical synthesis of novel, urea-containing FKBP12 inhibitors are described. These compounds are shown to disrupt the cis-trans peptidylprolyl isomerase activity of FKBP12 with inhibition constants (Ki,app) approaching 0.10 microM. Analyses of several X-ray crystal structures of FKBP12-urea complexes demonstrate that the urea-containing inhibitors associate with FKBP12 in a manner that is similar to, but significantly different from, that observed for the natural product FK506.
No takes yet. Share an insight, caveat, or question.
Dragovich et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: